IDO2 and cancer: Although the cytolytic effect of IDO2-specific class I-restricted lymphocytes in peripheral blood of healthy subjects against IDO2-expressing cells has still to be proven in vivo, Sørensen et al. hypothesize that the sizable reactivity to IDO2-derived antigens in normal individuals contributes to immune surveillance against cancer [66].